Rolapitant Plus Olanzapine in Multiday Cisplatin Chemotherapy

Clinical trial NCT03960151 · WITHDRAWN

Trial details

NCT number: NCT03960151
Sponsor: Costantine Albany
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Germ Cell Tumor

Start date: 2018-05-01
Primary completion: 2021-05-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.